Avidity Biosciences Research and Development Expenses 2019-2024 | RNA
Avidity Biosciences research and development expenses for the twelve months ending September 30, 2024 were $0.261B, a 41.92% increase year-over-year.
- Avidity Biosciences annual research and development expenses for 2023 were $0.191B, a 26.97% increase from 2022.
- Avidity Biosciences annual research and development expenses for 2022 were $0.15B, a 48.65% increase from 2021.
- Avidity Biosciences annual research and development expenses for 2021 were $0.101B, a 169.09% increase from 2020.